Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHA:600436)
China
· Delayed Price · Currency is CNY 204.05
+0.05 (0.02%)
May 29, 2025, 2:45 PM CST
SHA:600436 Revenue
Zhangzhou Pientzehuang Pharmaceutical., had revenue of 3.14B CNY in the quarter ending March 31, 2025, a decrease of -0.92%. This brings the company's revenue in the last twelve months to 10.76B, up 1.50% year-over-year. In the year 2024, Zhangzhou Pientzehuang Pharmaceutical., had annual revenue of 10.79B with 7.25% growth.
Revenue (ttm)
10.76B
Revenue Growth
+1.50%
P/S Ratio
11.45
Revenue / Employee
3.79M
Employees
2,839
Market Cap
123.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79B | 729.37M | 7.25% |
| Dec 31, 2023 | 10.06B | 1.36B | 15.69% |
| Dec 31, 2022 | 8.69B | 672.45M | 8.38% |
| Dec 31, 2021 | 8.02B | 1.51B | 23.20% |
| Dec 31, 2020 | 6.51B | 788.51M | 13.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |
| Beijing Wantai Biological Pharmacy Enterprise | 1.89B |